Error in Supplement - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Updated Supplement for the German Birth Cohort Study of Atopic Dermatitis Incidence and Remission

  • November 5, 2026

Share

Objective:

To report a correction to Supplement 1 accompanying the original investigation of atopic dermatitis among participants in a German birth cohort.

Approach:
  • Correction: A correction was issued after Supplement 1 appeared in an erroneous form in the December 8, 2025, publication.
Key Findings:
  • The correction concerns Supplement 1 of the original investigation of atopic dermatitis among participants in a German birth cohort.
Interpretation:

The correction notice reports that Supplement 1 appeared in an erroneous form and that a correction was issued.

Limitations:
  • The supplied context does not describe the original study methods or results.

Original Source(s)

Error in Supplement

  • November 5, 2026

Related Content

Does Baseline Severity of Atopic Dermatitis Impact the Long-Term Efficacy of Abrocitinib? Post-hoc Analysis of Two Randomized Trials

Asymptomatic Tattoo-Associated Cutaneous Nontuberculous Mycobacterial Infection: Case Report

Alopecia therapy gains FDA breakthrough status

The designation covers an investigational botanical treatment for moderate-to-severe alopecia areata in patients aged 2 years and older.